CytomX Therapeutics Statistics
Total Valuation
CTMX has a market cap or net worth of $711.89 million. The enterprise value is $368.04 million.
| Market Cap | 711.89M |
| Enterprise Value | 368.04M |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CTMX has 217.70 million shares outstanding. The number of shares has increased by 86.87% in one year.
| Current Share Class | 217.70M |
| Shares Outstanding | 217.70M |
| Shares Change (YoY) | +86.87% |
| Shares Change (QoQ) | +4.47% |
| Owned by Insiders (%) | 0.52% |
| Owned by Institutions (%) | 83.69% |
| Float | 186.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.03 |
| Forward PS | 23.90 |
| PB Ratio | 2.22 |
| P/TBV Ratio | 2.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.38, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.38 |
| Quick Ratio | 10.21 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.29% and return on invested capital (ROIC) is -21.72%.
| Return on Equity (ROE) | -34.29% |
| Return on Assets (ROA) | -16.89% |
| Return on Invested Capital (ROIC) | -21.72% |
| Return on Capital Employed (ROCE) | -19.01% |
| Weighted Average Cost of Capital (WACC) | 15.68% |
| Revenue Per Employee | $515,101 |
| Profits Per Employee | -$900,623 |
| Employee Count | 69 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CTMX has paid $235,000 in taxes.
| Income Tax | 235,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +52.80% in the last 52 weeks. The beta is 2.09, so CTMX's price volatility has been higher than the market average.
| Beta (5Y) | 2.09 |
| 52-Week Price Change | +52.80% |
| 50-Day Moving Average | 3.72 |
| 200-Day Moving Average | 4.08 |
| Relative Strength Index (RSI) | 48.20 |
| Average Volume (20 Days) | 4,276,643 |
Short Selling Information
The latest short interest is 28.72 million, so 13.19% of the outstanding shares have been sold short.
| Short Interest | 28.72M |
| Short Previous Month | 31.13M |
| Short % of Shares Out | 13.19% |
| Short % of Float | 15.42% |
| Short Ratio (days to cover) | 9.27 |
Income Statement
In the last 12 months, CTMX had revenue of $35.54 million and -$62.14 million in losses. Loss per share was -$0.39.
| Revenue | 35.54M |
| Gross Profit | 35.54M |
| Operating Income | -61.86M |
| Pretax Income | -58.91M |
| Net Income | -62.14M |
| EBITDA | -60.62M |
| EBIT | -61.86M |
| Loss Per Share | -$0.39 |
Balance Sheet
The company has $346.71 million in cash and $2.86 million in debt, with a net cash position of $343.85 million or $1.58 per share.
| Cash & Cash Equivalents | 346.71M |
| Total Debt | 2.86M |
| Net Cash | 343.85M |
| Net Cash Per Share | $1.58 |
| Equity (Book Value) | 319.94M |
| Book Value Per Share | 1.47 |
| Working Capital | 319.07M |
Cash Flow
In the last 12 months, operating cash flow was -$80.09 million and capital expenditures -$101,000, giving a free cash flow of -$80.19 million.
| Operating Cash Flow | -80.09M |
| Capital Expenditures | -101,000 |
| Depreciation & Amortization | 1.24M |
| Net Borrowing | n/a |
| Free Cash Flow | -80.19M |
| FCF Per Share | -$0.37 |
Margins
Gross margin is 100.00%, with operating and profit margins of -174.04% and -166.40%.
| Gross Margin | 100.00% |
| Operating Margin | -174.04% |
| Pretax Margin | -165.74% |
| Profit Margin | -166.40% |
| EBITDA Margin | -170.54% |
| EBIT Margin | -174.04% |
| FCF Margin | n/a |
Dividends & Yields
CTMX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -86.87% |
| Shareholder Yield | -86.87% |
| Earnings Yield | -8.73% |
| FCF Yield | -11.26% |
Analyst Forecast
The average price target for CTMX is $12.50, which is 282.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.50 |
| Price Target Difference | 282.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | -22.35% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTMX has an Altman Z-Score of 5.81 and a Piotroski F-Score of 1.
| Altman Z-Score | 5.81 |
| Piotroski F-Score | 1 |